INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/14/2026
Back to search
Official data from USPTO
QUANTINOVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QUANTINOVA
ST13
US500000079144043Class
1, 5
Filing
79144043
Registration
4603851
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/15/2026
Trademark type
Word
Nice classes
1, 5
Filing date
10/16/2013
Registration date
09/16/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/19/2025
Last transaction
04/15/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Hilden, DE
Examiner
ELTON, DAVID JONATHAN
Current location
Historical data usage
Holders and representatives
Holders
Qiagen GmbH
Qiagen GmbH
Representatives
VICTORIA FRIEDMAN Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological products for industrial and scientific purposesreagents and solvents for scientific and research use in the nature of sample preparation and for conducting markingseparatingisolatingpurifyingduplicating and analysis methods for biopolymersnucleic acids and enzymes; polymerase chain reaction (PCR) reagents for industrial and scientific purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; chemical reagents for conversion of RNA into cDNA for scientific research purposes; test kits comprising chemical preparations for industrial and scientific purposeskits comprising reagents and solvents for scientific research use for conducting markingseparatingisolatingpurifyingduplicating and analysis methods for biopolymersnucleic acidskits comprising polymerase chain reaction (PCR) reagents for industrial and scientific research purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; kits comprising chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; kits comprising chemical reagents for conversion of RNA into cDNA for scientific research purposes
Class 5
Diagnostic reagents for medical and veterinary medical purposesmedical diagnostic reagents for conducting markingseparatingisolatingpurifyingduplicating and analysis methods for biopolymersnucleic acids and enzymes; polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposeskits comprising medical diagnostic reagents for conducting markingseparatingisolatingpurifyingduplicating and analysis methods for biopolymersnucleic acids; kits comprising polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; kits comprising reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes
Publications
History of USPTO decisions and trademark events.
40 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/19/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/19/2025
71AG
REGISTERED-SEC.71 ACCEPTED
02/19/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/18/2025
ES71
TEAS SECTION 71 RECEIVED
08/30/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/16/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/31/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/03/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/20/2021
INPC
INVALIDATION PROCESSED
09/20/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/05/2021
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
01/05/2021
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
01/05/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/07/2020
ES75
TEAS SECTION 71 & 15 RECEIVED
08/21/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/18/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/13/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/24/2015
FIMP
FINAL DISPOSITION PROCESSED
02/24/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/16/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
09/16/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/22/2014
PUBO
PUBLISHED FOR OPPOSITION
07/01/2014
NPUB
NOTICE OF PUBLICATION
06/11/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/27/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/15/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2014
ALIE
ASSIGNED TO LIE
05/14/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2014
RFNT
REFUSAL PROCESSED BY IB
04/18/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/31/2014
RFRR
REFUSAL PROCESSED BY MPU
03/31/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/30/2014
CNRT
NON-FINAL ACTION WRITTEN
03/29/2014
MAFR
APPLICATION FILING RECEIPT MAILED
03/25/2014
DOCK
ASSIGNED TO EXAMINER
03/21/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/21/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/20/2014
Continuous trademark protection
Get notified about every new filing that threatens QUANTINOVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.